Nu-Med Plus (NUMD) Stock Statistics & Valuation Metrics
Total Valuation
Nu-Med Plus has a market cap or net worth of $601.55K. The enterprise value is $911.93B.
- Market Cap
- $601.55K
- Enterprise Value
- $911.93B
Share Statistics
Nu-Med Plus has 83,548,470 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 83,548,470
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Nu-Med Plus’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 30.83%.
- Return on Equity (ROE)
- 0.21
- Return on Assets (ROA)
- -7.10
- Return on Invested Capital (ROIC)
- 30.83%
- Return on Capital Employed (ROCE)
- 0.18
- Revenue Per Employee
- 0
- Profits Per Employee
- -28.09K
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Nu-Med Plus is -24.00. Nu-Med Plus’s PEG ratio is -0.60.
- PE Ratio
- -24.00
- PS Ratio
- 0.00
- PB Ratio
- -2.25
- Price to FCF
- -11.27
- Price to Operating Cash Flow
- -11.27
- PEG Ratio
- -0.60
Income Statement
In the last 12 months, Nu-Med Plus had revenue of 0 and earned -56.18K in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -48.95K
- Pretax Income
- -56.18K
- Net Income
- -56.18K
- EBITDA
- -48.95K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -53.39K and capital expenditures 0, giving a free cash flow of -53.39K billion.
- Operating Cash Flow
- -53.39K
- Free Cash Flow
- -53.39K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Nu-Med Plus pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8.88%
- Earnings Yield
- -3.46%
Stock Price Statistics
- Beta
- 1.42
- 52-Week Price Change
- -72.97%
- 50-Day Moving Average
- 0.02
- 200-Day Moving Average
- 0.01
- Relative Strength Index (RSI)
- 1.41
- Average Volume (3m)
- 61.33K
Financial Position
Nu-Med Plus as a current ratio of 0.03, with Debt / Equity ratio of -41.47%
- Current Ratio
- 0.03
- Quick Ratio
- 0.03
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- -2.28
- Interest Coverage Ratio
- 6.77
Taxes
In the past 12 months, Nu-Med Plus has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Nu-Med Plus EV to EBITDA ratio is -12.94, with an EV/FCF ratio of -13.46.
- EV to Sales
- 0.00
- EV to EBITDA
- -12.94
- EV to Free Cash Flow
- -13.46
- EV to Operating Cash Flow
- -13.46
Balance Sheet
Nu-Med Plus has $5,409.00 in cash and marketable securities with $122.50K in debt, giving a net cash position of -$117.09K billion.
- Cash & Marketable Securities
- $5,409.00
- Total Debt
- $122.50K
- Net Cash
- -$117.09K
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Nu-Med Plus is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 71.43%
